The Effect of Early Screening and Intervention for Gestational Diabetes Mellitus on Pregnancy Outcomes (TESGO)
Pregnancy Complications, Gestational Diabetes Mellitus in Pregnancy
About this trial
This is an interventional prevention trial for Pregnancy Complications focused on measuring early screening, early intervention, gestational diabetes mellitus, pregnancy outcomes, randomized controlled trial
Eligibility Criteria
Inclusion Criteria:
- Age ≥ 20 years old
- First prenatal visit before 14 weeks of GA
- Deliver a singleton at medical centers, including National Taiwan University Hospital (NTUH), and NTUH, Hsinchu Branch.
Exclusion Criteria:
- Diagnosed with preexisting diabetes
- Twin or multiple births pregnancy
- Current exposure to steroids
- Cannot tolerate an OGTT
Sites / Locations
- Department of Internal Medicine, National Taiwan University Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Early-screen Group
Standard-screen Group
The early screening group will be screened by a 75g 2-hour oral glucose tolerance test (OGTT) at 18-20 weeks of gestational age (GA). The time of early screening and intervention will be 6-8 weeks earlier than that of standard screening and intervention.
The standard screening group will be screened by a 75g 2-hour oral glucose tolerance test (OGTT) at 24-28 weeks of gestational age (GA). The time of standard screening and intervention will be 6-8 weeks later than that of early screening and intervention.